Published in
Elsevier, Alzheimer's && Dementia :: Translational Research && Clinical Interventions, 1(8), 2022
DOI: 10.1002/trc2.12299
Links
Tools
A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia
Journal article published in 2022 by
Lucy Vivash 
,
Charles B. Malpas,
Christian Meletis,
Meghan Gollant,
Dhamidhu Eratne,
Qiao‐Xin Li,
Stuart McDonald ,
William T. O'Brien,
Amy Brodtmann,
David Darby,
Christopher Kyndt,
Mark Walterfang,
Christopher M. Hovens,
Dennis Velakoulis,
Terence J. O'Brien
,
Charles B. Malpas,
Christian Meletis,
Meghan Gollant,
Dhamidhu Eratne,
Qiao‐Xin Li,
Stuart McDonald ,
William T. O'Brien,
Amy Brodtmann,
David Darby,
Christopher Kyndt,
Mark Walterfang,
Christopher M. Hovens,
Dennis Velakoulis,
Terence J. O'Brien
This paper is made freely available by the publisher.
Full text: Download
Data provided by 